Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer

Author： Recchia Francesco   Saggio Gaetano   Cesta Alisia   Candeloro Giampiero   Blasio Anna   Amiconi Giovanna   Lombardo Marco   Nuzzo Antonio   Lalli Angelo   Alesse Edoardo   Necozione Stefano   Rea Silvio  

Publisher： Springer Publishing Company

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.56, Iss.5, 2007-05, pp. : 699-708

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Maintenance Therapy with 13-cis Retinoid Acid in High-Grade Glioma at Complete Response After First-Line Multimodal Therapy – A Phase-II Study

By Wismeth Caecilia   Hau Peter   Fabel Klaus   Baumgart Ulrike   Hirschmann Birgit   Koch Horst   Jauch Tanja   Grauer Oliver   Drechsel Lisa   Brawanski Alexander   Bogdahn Ulrich   Steinbrecher Andreas  

Journal of Neuro-Oncology, Vol. 68, Iss. 1, 2004-05 ,pp. : 79-86

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer

By Goto Ayumu   Yamada Yasuhide   Hosokawa Ayumu   Ura Takashi   Arai Tatsuhiro   Hamaguchi Tetsuya   Muro Kei   Shimada Yasuhiro   Shirao Kuniaki  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 364-368

Springer Publishing Company

Access to resources Recommend Favorite

13-cis-Retinoic Acid or All-trans-Retinoic Acid plus Interferon- in Recurrent Cervical Cancer: A Southwest Oncology Group Phase II Randomized Trial

By Weiss G.R.   Liu P.Y.   Alberts D.S.   Peng Y.-M.   Fisher E.   Xu M.J.   Scudder S.A.   Baker L.H.   Moore D.F.   Lippman S.M.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 386-390

Elsevier

Access to resources Recommend Favorite

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

By Lobo Christopher   Lopes Gilberto   Baez Odalys   Castrellon Aurelio   Ferrell Annapoorna   Higgins Connie   Hurley Erin   Hurley Judith   Reis Isildinha   Richman Stephen   Seo Pearl   Silva Orlando   Slingerland Joyce   Tukia Keleni   Welsh Catherine   Glück Stefan  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 427-435

Springer Publishing Company

Access to resources Recommend Favorite

Temozolomide and 13- cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05)

By Grauer Oliver  

Journal of Neuro-Oncology, Vol. 104, Iss. 3, 2011-09 ,pp. : 801-809

Springer Publishing Company

Access to resources Recommend Favorite